In silico assessment of coriander leaf extract active compound to resensitize oxaliplatin resistance in colorectal cancer mediated by ABCG2 and UPF1 proteins

Colorectal cancer is, and continues to be, one of the most important global health burdens due to its notorious high mortality rate and continuous resilience to traditional modes of treatment, specifically chemotherapeutic agents such as oxaliplatin. The resistance is mediated through specified gen...

Full description

Saved in:
Bibliographic Details
Main Authors: Sun JESSICA, Sandra B. FILEMON, Sharron SANTOSA, Stephani C. MAHARANI, Arli A. PARIKESIT
Format: Article
Language:English
Published: Society of Land Measurements and Cadastre from Transylvania (SMTCT) 2024-12-01
Series:Notulae Scientia Biologicae
Subjects:
Online Access:https://www.notulaebiologicae.ro/index.php/nsb/article/view/12125
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846114178812608512
author Sun JESSICA
Sandra B. FILEMON
Sharron SANTOSA
Stephani C. MAHARANI
Arli A. PARIKESIT
author_facet Sun JESSICA
Sandra B. FILEMON
Sharron SANTOSA
Stephani C. MAHARANI
Arli A. PARIKESIT
author_sort Sun JESSICA
collection DOAJ
description Colorectal cancer is, and continues to be, one of the most important global health burdens due to its notorious high mortality rate and continuous resilience to traditional modes of treatment, specifically chemotherapeutic agents such as oxaliplatin. The resistance is mediated through specified genes highly involved in survival and resistant mechanisms in cancerous cells, like ABCG2 and UPF1 genes. Given the challenge, this study focuses on the coriander leaf extract as a new strategy for overcoming oxaliplatin resistance in colorectal cancer. In the present study, the authors examined the anticancer activities of the extracts from coriander leaves, which exerted inhibitory activity toward ABCG2 and UPF1 proteins believed to be involved in chemoresistance. Molecular docking analysis was done by PyRx software to evaluate the binding properties of the target genes with the 31 compounds in coriander leaf extract to find the best compound that may give an efficient way of overcoming resistance against oxaliplatin. Out of all the compounds screened, rutin came out to be the potential candidate. The binding affinities were highly impressive, about -8.4 kcal/mol for UPF1 and -7.8 kcal/mol for ABCG2. These values are especially important because they exceed the conventional affinity of known chemotherapy inhibitors, such as Ko143 and actinomycin D, which served as positive controls in this study. The higher binding affinity of rutin indicates that it may potentiate chemotherapy by specifically targeting ABCG2 and UPF1 in colorectal cancer cells. This strategic approach could limit the resistance to oxaliplatin and increase the treatment success rate in colorectal cancer patients. The observations of this work open up new perspectives in the study of natural products as adjuvants or alternatives to traditional chemotherapy that, in the future, could give rise to more efficient and less toxic strategies against colorectal cancer.
format Article
id doaj-art-b1de846f9f1746c187657932e9b53425
institution Kabale University
issn 2067-3264
language English
publishDate 2024-12-01
publisher Society of Land Measurements and Cadastre from Transylvania (SMTCT)
record_format Article
series Notulae Scientia Biologicae
spelling doaj-art-b1de846f9f1746c187657932e9b534252024-12-20T17:02:28ZengSociety of Land Measurements and Cadastre from Transylvania (SMTCT)Notulae Scientia Biologicae2067-32642024-12-0116410.55779/nsb16412125In silico assessment of coriander leaf extract active compound to resensitize oxaliplatin resistance in colorectal cancer mediated by ABCG2 and UPF1 proteinsSun JESSICA0Sandra B. FILEMON1Sharron SANTOSA2Stephani C. MAHARANI3Arli A. PARIKESIT4Indonesia International Institute for Life Sciences, Department of Biomedicine, JakartaIndonesia International Institute for Life Sciences, Department of Biotechnology, JakartaIndonesia International Institute for Life Sciences, Department of Biotechnology, JakartaIndonesia International Institute for Life Sciences, Department of Biotechnology, JakartaIndonesia International Institute for Life Sciences, Department of Bioinformatics, Jakarta Colorectal cancer is, and continues to be, one of the most important global health burdens due to its notorious high mortality rate and continuous resilience to traditional modes of treatment, specifically chemotherapeutic agents such as oxaliplatin. The resistance is mediated through specified genes highly involved in survival and resistant mechanisms in cancerous cells, like ABCG2 and UPF1 genes. Given the challenge, this study focuses on the coriander leaf extract as a new strategy for overcoming oxaliplatin resistance in colorectal cancer. In the present study, the authors examined the anticancer activities of the extracts from coriander leaves, which exerted inhibitory activity toward ABCG2 and UPF1 proteins believed to be involved in chemoresistance. Molecular docking analysis was done by PyRx software to evaluate the binding properties of the target genes with the 31 compounds in coriander leaf extract to find the best compound that may give an efficient way of overcoming resistance against oxaliplatin. Out of all the compounds screened, rutin came out to be the potential candidate. The binding affinities were highly impressive, about -8.4 kcal/mol for UPF1 and -7.8 kcal/mol for ABCG2. These values are especially important because they exceed the conventional affinity of known chemotherapy inhibitors, such as Ko143 and actinomycin D, which served as positive controls in this study. The higher binding affinity of rutin indicates that it may potentiate chemotherapy by specifically targeting ABCG2 and UPF1 in colorectal cancer cells. This strategic approach could limit the resistance to oxaliplatin and increase the treatment success rate in colorectal cancer patients. The observations of this work open up new perspectives in the study of natural products as adjuvants or alternatives to traditional chemotherapy that, in the future, could give rise to more efficient and less toxic strategies against colorectal cancer. https://www.notulaebiologicae.ro/index.php/nsb/article/view/12125colorectal cancercoriander leafmolecular dockingoxaliplatinrutin
spellingShingle Sun JESSICA
Sandra B. FILEMON
Sharron SANTOSA
Stephani C. MAHARANI
Arli A. PARIKESIT
In silico assessment of coriander leaf extract active compound to resensitize oxaliplatin resistance in colorectal cancer mediated by ABCG2 and UPF1 proteins
Notulae Scientia Biologicae
colorectal cancer
coriander leaf
molecular docking
oxaliplatin
rutin
title In silico assessment of coriander leaf extract active compound to resensitize oxaliplatin resistance in colorectal cancer mediated by ABCG2 and UPF1 proteins
title_full In silico assessment of coriander leaf extract active compound to resensitize oxaliplatin resistance in colorectal cancer mediated by ABCG2 and UPF1 proteins
title_fullStr In silico assessment of coriander leaf extract active compound to resensitize oxaliplatin resistance in colorectal cancer mediated by ABCG2 and UPF1 proteins
title_full_unstemmed In silico assessment of coriander leaf extract active compound to resensitize oxaliplatin resistance in colorectal cancer mediated by ABCG2 and UPF1 proteins
title_short In silico assessment of coriander leaf extract active compound to resensitize oxaliplatin resistance in colorectal cancer mediated by ABCG2 and UPF1 proteins
title_sort in silico assessment of coriander leaf extract active compound to resensitize oxaliplatin resistance in colorectal cancer mediated by abcg2 and upf1 proteins
topic colorectal cancer
coriander leaf
molecular docking
oxaliplatin
rutin
url https://www.notulaebiologicae.ro/index.php/nsb/article/view/12125
work_keys_str_mv AT sunjessica insilicoassessmentofcorianderleafextractactivecompoundtoresensitizeoxaliplatinresistanceincolorectalcancermediatedbyabcg2andupf1proteins
AT sandrabfilemon insilicoassessmentofcorianderleafextractactivecompoundtoresensitizeoxaliplatinresistanceincolorectalcancermediatedbyabcg2andupf1proteins
AT sharronsantosa insilicoassessmentofcorianderleafextractactivecompoundtoresensitizeoxaliplatinresistanceincolorectalcancermediatedbyabcg2andupf1proteins
AT stephanicmaharani insilicoassessmentofcorianderleafextractactivecompoundtoresensitizeoxaliplatinresistanceincolorectalcancermediatedbyabcg2andupf1proteins
AT arliaparikesit insilicoassessmentofcorianderleafextractactivecompoundtoresensitizeoxaliplatinresistanceincolorectalcancermediatedbyabcg2andupf1proteins